MSA has been shown to enhance the efficacy of chemotherapeutic drugs in cultured estrogen-receptor-positive breast cancer cells as well as cultured prostate cancer cells and prostate tumor xenografts [14]–[17]. The gene discussed is ESR1; the disease is breast carcinoma.